Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06624982 · ClinicalTrials.gov registry record
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
A clinical trial of Wound Healing and Alveolar Bone Grafting, sponsored by Marquette University.
- Recruiting
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT06624982: Recruiting study of Wound Healing and Alveolar Bone Grafting, sponsored by Marquette University.
NCT06624982 is a study of Wound Healing and Alveolar Bone Grafting that is actively recruiting participants, run by Marquette University. The registered enrollment target is 160 participants, above the 43-participant average among 11 other Wound Healing trials with a reported enrollment target (272% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06624982, a study of Wound Healing and Alveolar Bone Grafting, is actively recruiting participants, sponsored by Marquette University.
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of the study is to measure and localize immediate post extraction changes i.e. socket expansion versus no width change along the socket wall and identify whether the immediate post-extraction ridge width condition (expansion or no change) is a determinant of buccolingual ridge width and height changes 4 months following extraction and ridge preservation.
Primary Outcome
Buccolingual ridge width will be measured through a stent via ridge mapping calipers. The measurement locations will be at 1mm, 3mm and 5mm from the midbuccal crest. The same measurements will be recorded at all selected time points.
Conditions Studied
Interventions
- OTHER observational study
Study Locations (1)
Wisconsin
- Marquette University School of Dentistry Graduate Periodontics Clinic - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2025-10-08 |
| Est. Completion | 2027-10-01 |
What NCT06624982 shows while recruiting
NCT06624982 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, above the 43-participant average among 11 other Wound Healing trials with a reported enrollment target (272% higher).
The record links to 4 conditions, with Wound Healing appearing as the primary indexed condition, and to 1 intervention - of which observational study is the first listed.
NCT06624982 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06624982 about?
NCT06624982 is a clinical study titled "Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation". The main purpose of the study is to measure and localize immediate post extraction changes i.e. socket expansion versus no width change along the socket wall and identify whether the immediate post-extraction ridge width condition (expansion or no change) is a determinant of buccolingual ridge width...
What is the current status of trial NCT06624982?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2025-10-08. Estimated completion is 2027-10-01.
What conditions does trial NCT06624982 study?
This clinical trial studies the following conditions: Wound Healing, Alveolar Bone Grafting, Tooth Extraction Site Healing, Bone Healing.
What interventions are being tested in trial NCT06624982?
The interventions under investigation include: observational study (OTHER).
Who is sponsoring clinical trial NCT06624982?
This trial is sponsored by Marquette University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06624982 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Healing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06624982's enrollment target sits among peer trials
160 1st of 11 higher than 11 of 11 other Wound Healing trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wound Healing trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
RECRUITING · NA
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Dose Regimen Study of SLI-F06 in Healthy Volunteers
RECRUITING · Phase 2
-
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
RECRUITING · NA
-
NPWT Reduction Mammaplasty
RECRUITING · NA
-
Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI